Patents by Inventor Bob Carter

Bob Carter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of microvesicles in analyzing nucleic acid profiles
    Patent number: 11519036
    Abstract: The invention concerns gene signatures obtained from microvesicles and a method of applying these gene signatures in helping to determine a biological condition. The determination of a biological condition may aid, for example, the diagnosis, prognosis, and therapy treatment selection for disease in a subject.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: December 6, 2022
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Mikkel Noerholm, Johan Karl Olov Skog, Xandra O. Breakefield, Bob Carter
  • USE OF MICROVESICLES IN ANALYZING NUCLEIC ACID PROFILES
    Publication number: 20200017920
    Abstract: The invention concerns gene signatures obtained from microvesicles and a method of applying these gene signatures in helping to determine a biological condition. The determination of a biological condition may aid, for example, the diagnosis, prognosis, and therapy treatment selection for disease in a subject.
    Type: Application
    Filed: July 23, 2019
    Publication date: January 16, 2020
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Mikkel Noerholm, Johan Karl Olov SKOG, Xandra O. BREAKEFIELD, Bob Carter
  • VEGF-BINDING PROTEIN FOR BLOCKADE OF ANGIOGENESIS
    Publication number: 20190292239
    Abstract: Provided are chimeric VEGF-binding proteins and nucleic acids (e.g., a vector) encoding chimeric VEGF-binding proteins, methods and host cells for producing these proteins and nucleic acids, and pharmaceutical compositions containing these proteins and nucleic acids. Also provided are methods of treating an angiogenic disease or disorder that include administering at least one of the chimeric VEGF-binding proteins or at least one of the nucleic acids (e.g., a vector) encoding a chimeric VEGF-binding protein.
    Type: Application
    Filed: March 4, 2019
    Publication date: September 26, 2019
    Applicants: Children's Medical Center Corporation, The General Hospital Corporation, President and Fellows of Harvard College
    Inventors: Bob Carter, Jeng-Shin Lee, Szofia S. Bullain, Richard C. Mulligan
  • Use of microvesicles in analyzing nucleic acid profiles
    Patent number: 10407728
    Abstract: The invention concerns gene signatures obtained from microvesicles and a method of applying these gene signatures in helping to determine a biological condition. The determination of a biological condition may aid, for example, the diagnosis, prognosis, and therapy treatment selection for disease in a subject.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: September 10, 2019
    Assignee: The General Hospital Corporation
    Inventors: Mikkel Noerholm, Johan Karl Olov Skog, Xandra O. Breakefield, Bob Carter
  • VEGF-binding protein for blockade of angiogenesis
    Patent number: 10259862
    Abstract: Provided are chimeric VEGF-binding proteins and nucleic acids (e.g., a vector) encoding chimeric VEGF-binding proteins, methods and host cells for producing these proteins and nucleic acids, and pharmaceutical compositions containing these proteins and nucleic acids. Also provided are methods of treating an angiogenic disease or disorder that include administering at least one of the chimeric VEGF-binding proteins or at least one of the nucleic acids (e.g., a vector) encoding a chimeric VEGF-binding protein.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: April 16, 2019
    Assignees: Children's Medical Center Corporation, The General Hospital Corporation, President and Fellows of Harvard College
    Inventors: Bob Carter, Jeng-Shin Lee, Szofia S. Bullain, Richard C. Mulligan
  • VEGF-BINDING PROTEIN FOR BLOCKADE OF ANGIOGENESIS
    Publication number: 20180127483
    Abstract: Provided are chimeric VEGF-binding proteins and nucleic acids (e.g., a vector) encoding chimeric VEGF-binding proteins, methods and host cells for producing these proteins and nucleic acids, and pharmaceutical compositions containing these proteins and nucleic acids. Also provided are methods of treating an angiogenic disease or disorder that include administering at least one of the chimeric VEGF-binding proteins or at least one of the nucleic acids (e.g., a vector) encoding a chimeric VEGF-binding protein.
    Type: Application
    Filed: June 12, 2017
    Publication date: May 10, 2018
    Applicants: Children's Medical Center Corporation, The General Hospital Corporation, President and Fellows of Harvard College
    Inventors: Bob Carter, Jeng-Shin Lee, Szofia S. Bullain, Richard C. Mulligan
  • VEGF-binding protein for blockade of angiogenesis
    Patent number: 9701731
    Abstract: Provided are chimeric VEGF-binding proteins and nucleic acids (e.g., a vector) encoding chimeric VEGF-binding proteins, methods and host cells for producing these proteins and nucleic acids, and pharmaceutical compositions containing these proteins and nucleic acids. Also provided are methods of treating an angiogenic disease or disorder that include administering at least one of the chimeric VEGF-binding proteins or at least one of the nucleic acids (e.g., a vector) encoding a chimeric VEGF-binding protein.
    Type: Grant
    Filed: August 17, 2012
    Date of Patent: July 11, 2017
    Assignees: Children's Medical Center Corporation, The General Hospital Corporation, President and Fellows of Harvard College
    Inventors: Bob Carter, Jeng-Shin Lee, Szofia S. Bullain, Richard C. Mulligan
  • USE OF MICROVESICLES IN ANALYZING NUCLEIC ACID PROFILES
    Publication number: 20160002736
    Abstract: The invention concerns gene signatures obtained from microvesicles and a method of applying these gene signatures in helping to determine a biological condition. The determination of a biological condition may aid, for example, the diagnosis, prognosis, and therapy treatment selection for disease in a subject.
    Type: Application
    Filed: July 6, 2015
    Publication date: January 7, 2016
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Mikkel NOERHOLM, Johan Karl Olov SKOG, Xandra O. BREAKEFIELD, Bob CARTER
  • VEGF-BINDING PROTEIN FOR BLOCKADE OF ANGIOGENESIS
    Publication number: 20140302025
    Abstract: Provided are chimeric VEGF-binding proteins and nucleic acids (e.g., a vector) encoding chimeric VEGF-binding proteins, methods and host cells for producing these proteins and nucleic acids, and pharmaceutical compositions containing these proteins and nucleic acids. Also provided are methods of treating an angiogenic disease or disorder that include administering at least one of the chimeric VEGF-binding proteins or at least one of the nucleic acids (e.g., a vector) encoding a chimeric VEGF-bind ing protein.
    Type: Application
    Filed: August 17, 2012
    Publication date: October 9, 2014
    Applicants: CHILDREN'S MEDICAL CENTER CORPORATION, THE GENERAL HOSPITAL CORPORATION, PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Bob Carter, Jeng-Shin Lee, Szofia S. Bullain, Richard C. Mulligan
  • USE OF MICROVESICLES IN ANALYZING NUCLEIC ACID PROFILES
    Publication number: 20130040833
    Abstract: The invention concerns gene signatures obtained from microvesicles and a method of applying these gene signatures in helping to determine a biological condition. The determination of a biological condition may aid, for example, the diagnosis, prognosis, and therapy treatment selection for a disease in a subject.
    Type: Application
    Filed: September 9, 2010
    Publication date: February 14, 2013
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Mikkel Noerholm, Johan Karl Olov Skog, Xandra O. Breakefield, Bob Carter
  • Modular truck rack
    Patent number: D444446
    Type: Grant
    Filed: January 3, 2001
    Date of Patent: July 3, 2001
    Inventor: Bob Carter